Hsiao-ping Fang

Title: Hsiao-ping Fang: Innovator in Pharmaceutical Chemistry

Introduction

Hsiao-ping Fang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of 2 patents to his name, Fang's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Fang's latest patents include innovative formulations and processes. The first patent, titled "Forms of apremilast and the process of making the same," presents novel crystalline forms of apremilast, including hemitoluene solvate, hydrate, and anhydrate, along with an amorphous form. This invention outlines processes for the preparation of these forms, which could enhance the efficacy of treatments involving apremilast. The second patent, "Process for the preparation of abiraterone and intermediates thereof," provides intermediates for preparing abiraterone and details the processes involved. This patent includes a compound of formula (IV), where R represents a hydroxy-protecting group, showcasing Fang's expertise in synthetic chemistry.

Career Highlights

Hsiao-ping Fang is currently associated with Scinopharm Taiwan, Ltd., a company known for its focus on pharmaceutical development and manufacturing. His work at Scinopharm has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Fang has worked alongside notable colleagues such as Wei-Shuo Lo and Kuan Hsun Wang. These collaborations have likely fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Hsiao-ping Fang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments and drug formulations.